Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Among authors: gomis font ma. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
Agyeman AA, López-Causapé C, Rogers KE, Lucas DD, Cortés-Lara S, Gomis-Font MA, Fraile-Ribot P, Figuerola J, Lang Y, Franklyn ERT, Lee WL, Zhou J, Zhang Y, Bulitta JB, Boyce JD, Nation RL, Oliver A, Landersdorfer CB. Agyeman AA, et al. Among authors: gomis font ma. Int J Antimicrob Agents. 2023 Sep;62(3):106887. doi: 10.1016/j.ijantimicag.2023.106887. Epub 2023 Jun 12. Int J Antimicrob Agents. 2023. PMID: 37315906
Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients.
López-Causapé C, Maruri-Aransolo A, Gomis-Font MA, Penev I, Castillo MG, Mulet X, de Dios Caballero J, Campo RD, Cantón R, Oliver A. López-Causapé C, et al. Among authors: gomis font ma. Clin Microbiol Infect. 2023 Apr;29(4):538.e7-538.e13. doi: 10.1016/j.cmi.2022.11.014. Epub 2022 Nov 24. Clin Microbiol Infect. 2023. PMID: 36435424 Free article.
Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
Gomis-Font MA, Pitart C, Del Barrio-Tofiño E, Zboromyrska Y, Cortes-Lara S, Mulet X, Marco F, Vila J, López-Causapé C, Oliver A. Gomis-Font MA, et al. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0008921. doi: 10.1128/AAC.00089-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34060900 Free PMC article.
Emergence of Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations Due to Horizontally Acquired AmpC (FOX-4) in Pseudomonas aeruginosa Sequence Type 308.
Fraile-Ribot PA, Del Rosario-Quintana C, López-Causapé C, Gomis-Font MA, Ojeda-Vargas M, Oliver A. Fraile-Ribot PA, et al. Among authors: gomis font ma. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e02112-19. doi: 10.1128/AAC.02112-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31685471 Free PMC article. No abstract available.